CDKN2A and ductal breast carcinoma in situ: Another study on p16 expression in the stroma of ductal carcinoma in situ (DCIS) of the breast [29] provided evidence that DCIS with high stromal p16 expression tended to show estrogen receptor negativity and high Ki-67 labeling indices.